TRIM21 and Sjogren syndrome: TRIM21/Ro52 and the antibodies that target it (anti-TRIM21/Ro52) are involved in many autoimmune diseases, especially rheumatic diseases, such as systemic lupus erythematosus (SLE) and primary Sjögren’s syndrome (pSS) [8].